In vitro Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia

Thrombocytopenia is common among critically ill sepsis patients, while they also hold an increased risk for thromboembolic events. Thus, the choice of anticoagulant prophylaxis for this patient population is challenging. We investigated the in vitro effect of low-molecular-weight heparin (dalteparin...

Full description

Bibliographic Details
Main Authors: Søren Nygaard, Christine L. Hvas, Anne-Mette Hvas, Kasper Adelborg
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2023-01-01
Series:TH Open
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-2000-6576